These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 18223337

  • 1. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
    Müllauer L, Emhofer J, Wohlfart S, Pichlhöfer B, Stary S, Ebetsberger G, Mannhalter C, Chott A.
    Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
    [Abstract] [Full Text] [Related]

  • 2. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
    Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES.
    Am J Surg Pathol; 2005 Jul; 29(7):903-11. PubMed ID: 15958855
    [Abstract] [Full Text] [Related]

  • 3. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Puck JM, Sneller MC.
    Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
    [Abstract] [Full Text] [Related]

  • 4. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene.
    Gualco G, van den Berg A, Koopmans S, Bacchi LM, Carneiro SS, Ruiz E, Vecchi AP, Chan JK.
    Hum Pathol; 2008 Jan; 39(1):137-41. PubMed ID: 18070632
    [Abstract] [Full Text] [Related]

  • 5. Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature.
    Oren H, Ozkal S, Gülen H, Duman M, Uçar C, Atabay B, Yilmaz S, Kargi A, Irken G.
    Ann Hematol; 2002 Nov; 81(11):651-3. PubMed ID: 12454704
    [Abstract] [Full Text] [Related]

  • 6. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.
    Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES.
    Am J Surg Pathol; 2010 Apr; 34(4):589-94. PubMed ID: 20216376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathological findings in human autoimmune lymphoproliferative syndrome.
    Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W, Sneller MC, Puck JM, Lenardo MJ, Elenitoba-Johnson KS, Lin AY, Raffeld M, Jaffe ES.
    Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
    Worth A, Thrasher AJ, Gaspar HB.
    Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI, Pinto A, Auer IA, Bridges P, Luider J, Dimnik L, Patel KD, Jorgenson K, Woodman RC.
    Blood Cells Mol Dis; 1999 Apr; 25(3-4):227-38. PubMed ID: 10575548
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
    Avila NA, Dwyer AJ, Dale JK, Lopatin UA, Sneller MC, Jaffe ES, Puck JM, Straus SE.
    Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
    [Abstract] [Full Text] [Related]

  • 16. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
    Vacek MM, Schäffer AA, Davis J, Fischer RE, Dale JK, Adams S, Straus SE, Puck JM.
    Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
    Alvarado CS, Straus SE, Li S, Dale JK, Mann K, Le A, Lauer SJ.
    Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
    [Abstract] [Full Text] [Related]

  • 18. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
    Rieux-Laucat F.
    Curr Dir Autoimmun; 2006 Aug; 9():18-36. PubMed ID: 16394653
    [Abstract] [Full Text] [Related]

  • 19. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M, Mhatre S, Gupta M, Ghosh K.
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [Abstract] [Full Text] [Related]

  • 20. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
    Janić MD, Brasanac CD, Janković JS, Dokmanović BL, Krstovski RN, Kraguljac Kurtović JN.
    Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.